ReviewDer Nervenarzt2026
[Vulnerability factors of depressive relapses and recurrences].
Review in Der Nervenarzt, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepressive episodes are associated with a high risk of relapse and recurrence. A precise understanding of the risk factors for recurrence and relapse can prevent poor disease courses through the implementation of early and targeted interventions.
objectiveDescription of the factors that increase the risk of recurrence and relapse in major depression. MATERIAL AND
methodsNarrative literature review.
resultsRisk factors for depressive recurrence and relapse are primarily clinical factors, including the number of previous depressive episodes, a young age at first onset and existing residual symptoms. Environmental factors include childhood maltreatment and current stressors. Intrapsychic factors such as increased neuroticism or dysfunctional cognition also promote relapses and recurrences. Biological factors include functional and structural brain changes, immunological dysregulation and genetic predispositions.
conclusionIn clinical practice the previous course of illness is the key predictor for individual risk prognosis. Therapeutic interventions should focus on achieving full remission of residual symptoms through combined pharmacological and psychotherapeutic treatment. The vulnerability to recurrence of depressive episodes is multifactorial and the indications for recurrence prevention should reflect this.
Indexed as
Identifiers
41642335What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.